Table 5: Recipients and donors risk factors as predictors of outcome

Category Survival No  ( % ) p-value
Number of patients 92/ 161  (57.1%)
Graft type
Right lobe
Left lobe
91/153(59.5%)
1/8(12.5%)
.011
Actual GRWR > 0.8
Yes
No
87/145(60%) 5/16(31.3%) .027
Intraoperative blood transfusion>10 units
Yes
No
12/34(35.3%)
80/127(63%)
.004
Immunosuppression and steroid regimen
FK, MMF, steroids
Cyclosporine, MMF, steroids
Sirolomus, MMF, steroids
83/139(59.7%)
32/48(66.7%)
9/10(90%)
> 0.05
> 0.05
.002
Biliary complications
Yes
No
39/72(54.2%)
53/89(59.6%)
> 0.05
Vascular complications
Yes
No
13/34(38.2%)
79/127(62.2%)
.011
Small for size syndrome
Yes
No
4/19(21.1%)
88/142(62%)
.001


FK: Tacrolimus, MMF: Mycophenolate mofetil.